Skip to main content

C3 Inhibitors

C3 inhibitors are used to treat paroxysmal nocturnal hemoglobinuria. They work by preventing destruction of red blood cells and immune cell activation.

Why are c3 inhibitors prescribed?

  1. Macular Degeneration (50%)
  2. Paroxysmal Nocturnal Hemoglobinuria (50%)

Key takeaways

C3 inhibitors are used to treat paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy (GA) secondary to age-related macular degeneration. These medications work by inhibiting complement C3 proteins, which play a role in inflammation. C3 inhibitors are available as under-the-skin and into-the-eye injections. One example is pegcetacoplan (Empaveli, Syfovre).

Prices for popular C3 Inhibitors medications
Viewing 2 of 2 medications
PEGCETACOPLAN treats paroxysmal nocturnal hemoglobinuria (PNH), a condition that causes low levels of red blood cells (anemia) and blood clots. It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells.
PEGCETACOPLAN treats macular degeneration, a condition that can cause vision loss. It works by helping to slow changes in vision.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.